Jose M. Cordova-Recio

Salamanca, CL 37007, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Mineralocorticoid Receptor Antagonist Pre-Adrenalectomy in Primary Aldosteronism.

Mineralocorticoid Receptor Antagonist Pre-Adrenalectomy in Primary Aldosteronism.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 18, 2025

Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study.

Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study.

Journal: Journal of endocrinological investigation

Published: May 08, 2025

Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors.

Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors.

Journal: The Journal of clinical endocrinology and metabolism

Published: January 24, 2025

Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study.

Outcomes of transsphenoidal surgery for pituitary adenomas in Spain: a retrospective multicenter study.

Journal: Frontiers in endocrinology

Published: November 16, 2024

Glucose metabolism outcomes after pituitary surgery in patients with acromegaly.

Glucose metabolism outcomes after pituitary surgery in patients with acromegaly.

Journal: Pituitary

Published: June 15, 2024

Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up.

Current Management of Head and Neck Paragangliomas: A Multicenter Series With Long-Term Follow-Up.

Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Published: May 26, 2024

Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study.

Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study.

Journal: Frontiers in endocrinology

Published: May 04, 2024

Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature.

Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 09, 2024

Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.

Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.

Journal: Endocrine-related cancer

Published: March 02, 2024

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases.

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 20, 2023

Coexistence of GH-Producing Pituitary Macroadenoma and Meningioma in a Patient with Multiple Endocrine Neoplasia Type 1 with Hyperglycemia and Ketosis as First Clinical Sign.

Coexistence of GH-Producing Pituitary Macroadenoma and Meningioma in a Patient with Multiple Endocrine Neoplasia Type 1 with Hyperglycemia and Ketosis as First Clinical Sign.

Journal: Case reports in endocrinology

Published: June 29, 2017

Consensus document of the Neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition on management of hypopituitarism during transition.

Consensus document of the Neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition on management of hypopituitarism during transition.

Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

Published: June 18, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026